Advertisement

Search Results for "pharma-and-biotech-firms"

Forbes List Logo
India's pharma firms see strong growth
India's pharmaceutical firms reported strong earnings growth for the June-ended quarter, led by higher sales of drugs for chronic ailments and strong business for the API segment. The outlook for comi
BySalil Panchal
Trump demands lower drug prices, warns of penalties for pharma firms
ByAFP
Words consumers and firms use can be deal-breakers: INSEAD's Abhishek Borah
ByAnitha Moosath
India's top 25 venture capital firms
BySayan Chakraborty
India's Agri-Biotech Cliff
BySeema Singh
Fermenta Biotech Limited: Delivering sunshine globally
ByBrand Connect
The Covid-19 opportunity for India's biotech startups
ByPadmaja Ruparel
Fermenta Biotech: Lucre in sheep's clothing
ByNaini Thaker
The rise and rise of family firms
ByKavil Ramachandran,Nupur Pavan Bang
Covid-19 vaccine: Bharat Biotech to start human trials
ByForbes India
Katherine Eban: Ranbaxy and the dark side of Indian pharma
ByPooja Sarkar
The Link Between Good Governance And Green Firms
ByIE
VIDEO: Why RIL bought Netmeds, and what this means for e-pharma
ByForbes India
...

Latest News

Photo of the day: India Art Fair kicks off in Delhi
ByForbes India
RBI likely to hold interest rates in February 6 policy meet
BySalil Panchal
Economists flag upside to India growth after US tariff deal, but hold forecasts
BySamreen Wani
Why current tech stacks will fail DPDP (And what needs to change)
ByRoshmik Saha
Non-veg milk: The bone of contention in India-US trade deal
BySamidha Jain
Graphic of the day: Tariff relief cost: $2.5 trillion
BySamreen Wani
Why India’s IT giants are worried about Anthropic’s Claude Cowork
ByNaini Thaker
India’s concert economy: Booming sales, lagging infrastructure
ByNaini Thaker,Himani Kothari
AI agents form their own social network, humans left fascinated and alarmed
ByNaini Thaker
Advertisement
Advertisement

On Everyone’s Radar

Advertisement